BRIEF published on 01/20/2025 at 07:35, 1 year 7 months ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués Poxel annonce l'atteinte des 5 milliards de yens de ventes nettes de TWYMEEG® au Japon, entraînant des redevances croissantes et un paiement basé sur les ventes. Échéances de remboursement et perspective positive Japon Ventes Nettes Poxel TWYMEEG Redevances
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 7 months ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
BRIEF published on 12/23/2024 at 07:35, 1 year 8 months ago Poxel Releases Half-Year Financial Report for 2024 Financial Report 2024 Biopharmaceutical Poxel Audit Review
BRIEF published on 12/23/2024 at 07:35, 1 year 8 months ago Poxel publie son rapport financier semestriel pour 2024 Biopharmaceutique Rapport Financier 2024 Poxel Examen D'audit
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 8 months ago Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report Poxel SA announces availability of its 2024 half-year financial report, including condensed financial statements and activities for June 30, 2024 Biopharmaceutical Company Metabolic Disorders MASH 2024 Half-Year Financial Report Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 8 months ago Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel POXEL SA annonce la mise à disposition de son rapport financier semestriel au 30 juin 2024, incluant comptes consolidés, rapport d'activité et attestation Euronext Biopharmaceutique Maladies Métaboliques Rapport Financier Semestriel Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 8 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
BRIEF published on 12/09/2024 at 07:35, 1 year 8 months ago Poxel Announces Financial Challenges and Outlines Future Strategy Financial Results General Meeting Bonds Redemption Cash Runway Poxel SA
BRIEF published on 12/09/2024 at 07:35, 1 year 8 months ago Poxel annonce ses défis financiers et présente sa stratégie future Résultats Financiers Assemblée Générale Remboursement Des Obligations Poxel SA Piste De Trésorerie
Published on 09/05/2026 at 04:05, 2 days 5 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 9 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 10 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 10 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days 18 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/07/2026 at 09:00, 27 minutes ago Original-Research: NanoRepro AG (von NuWays AG): BUY
Published on 09/07/2026 at 08:59, 28 minutes ago Heidelberg Pharma to Present New Clinical Data on Lead ATAC Candidate Pamlectabart Tismanitin at International Myeloma Society Annual Meeting 2026
Published on 09/07/2026 at 08:30, 57 minutes ago Dépôt d’une actualisation du document d’enregistrement universel
Published on 09/07/2026 at 08:25, 1 hour 2 minutes ago Dépôt d’une actualisation du document d’enregistrement universel
Published on 09/07/2026 at 08:20, 1 hour 7 minutes ago Derichebourg annonce le lancement d’une offre d’obligations vertes senior
Published on 09/04/2026 at 18:57, 2 days 14 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 2 days 14 hours ago Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
